Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Also if you cant get it up you are going to be angry as hell anyway.
Sorry but it never did work for everyone.
Eroxon is targeting the 60% of men it does work for.
multiply that by 300 million men world wide that suffer ED and you can see just a small market share capture will be huge for futura.
Futura reckon they have grabbed 20% in current live markets
Welcome "cooling" relief for the nether regions and gives confidence of the product despite the negative reviews on Boots online website, fortunately I topped up at the bottom this week . Market has reacted well to the news it seems
News broke late in the day, so hoping for further gains tomorrow. What a pleasant surprise when I logged back on!
Fumble Medical in all its glory
Smashed through +10% 👍
Fuzzbox, too true. I rip into restaurants, hotels and the like with my comments when the service / product is awful but when it does what is says on the can, I usually forget to say so.
So great, we have the recognition from Boots. Let's hope that our reward follows closely behind.
If life is good, if the products and services are awesome, do you then set aside time to go online and leave a review? Nope…
However, if you feel ripped-off, or angry that something wasn’t good or didn’t work… do you then have the rage and motivation to complain, setting aside time to leave a bad review. Of course.
And with a product like ours, if it’s working well…. you definitely will be preoccupied with something else and will be too busy to leave a positive review.
Once there is further clarity on US launch I expect that 121p average price target to be revised alot higher
Haleon are huge
Yep, I have tried the product and worked for me but I don't like the flood of bad reviews. Bad reviews put me off always but this time I made an exception given I wanted to try it out for investment purposes. Hence, I believe there might be a % of users who become loyal buyers but the market is not as big as it could have been with better market reception
Despite all those negative reviews too..
Excellent news. great endorsement, which i imagine fum/coopers will be able to use to great advantage in the advertising/publicity area.
Haha fuzz, beautifully put. Surfie sir, those bed wetters are now drying off
Finally BOD rubbed some gel on their braincells and got a positive thought to put out an RNS of positive news for a change…
The product of the year has just punched through 30p
See Rns 15 mins ago!
The clouds are parting and now a bit of blue. Buy big time!... totally oversold, nice bounce soon.
Oversold. And with an analyst price target of 126p.
I'm looking forward to the next official revenue figures.
Wonder if its time (7 months in) for the tubes to be sold Individually or in pack of 2 . Given a average price of £5/6 and £11/12 respectively may it more appealing competing with or working with two pack Viagra connect £11 as opposed to spending North of £20 on a bulky box for fiddly little tubes. The recreation ease of use Market is the one they want.
the issue of using it 4 times is understandable in roleout but assuming now its repeat buyers
Also wonder what sales doing as there are now so many outlets selling
Holdings RNS in the near future and major news any day.
When it moves it will hit £1.00
Always a dip before Xmas apart from 2022, they must of f’d up! I know I’m prob not helping here but very annoyed with the BOD!
Maybe Barder & the cronies are the problem, the lower it goes the better for them! Or maybe I’m just paranoid??
“Directors receive 25-30 per cent of their remuneration in the form of Ordinary Shares. For 2022, these were issued at 36.36 pence per share, being the average closing mid-market price of the last 10 trading days of 2021 (as announced via RNS on 13 January 2022).”
" I don’t agree people wouldn’t buy to try Eroxon based on the reviews as the reviews state it either works or doesn’t!"
Been invested here for a while but dont really frequent the boards very much. You can take this as anecdotal but for me it was very much fact/1st hand experience.
Years ago I worked in Maritime sailing various seas and oceans. We used to stop in various countries and often stayed for a number of days. One being Sri Lanka. Enhancing drugs such as Viagra were available at the time and the blokes used to by them all th e time.
In short they never really worked unless you had a willing female taking part. Blokes used to take them just to see what happened. Not a lot if you was just sat on your bed on your own.
But "Gee Whizz" was the reply I would get from my wrestling partner when I popped up. So erect it would bloody hurt.
AIM companies can and do transfer to main market for many reasons, one being improved liquidity. Brings companies under the analyst's spotlight. I, like most on this BB expected this to be going in the opposite direction, culminating in a huge MC and FTSE move.
FUM is listed on AIM and as such is not eligible for the FTSE UK index series such as the FTSE 250 or FTSE All Share, irrespective of market cap. It would to change market segment , so it is part of the FTSE AIM All Shares index